241 related articles for article (PubMed ID: 31651851)
1. Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus. An observational, cross-sectional, multicenter study in Spain from the risk/systemic lupus erythematosus thematic network.
Fernández-Garcés M; Haro G; Micó ML
Medicine (Baltimore); 2019 Oct; 98(43):e17489. PubMed ID: 31651851
[TBL] [Abstract][Full Text] [Related]
2. Maternal-placental syndrome and future risk of accelerated cardiovascular events in Parous Swedish women with systemic lupus erythematosus - a population-based retrospective cohort study with time-to-event analysis.
Soh MC; Dib F; Nelson-Piercy C; Westgren M; McCowan L; Pasupathy D
Rheumatology (Oxford); 2016 Jul; 55(7):1235-42. PubMed ID: 27016663
[TBL] [Abstract][Full Text] [Related]
3. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.
Gustafsson J; Gunnarsson I; Börjesson O; Pettersson S; Möller S; Fei GZ; Elvin K; Simard JF; Hansson LO; Lundberg IE; Larsson A; Svenungsson E
Arthritis Res Ther; 2009; 11(6):R186. PubMed ID: 20003285
[TBL] [Abstract][Full Text] [Related]
4. Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
Quevedo-Abeledo JC; Rúa-Figueroa Í; Sánchez-Pérez H; Tejera-Segura B; de Vera-González A; González-Delgado A; Llorca J; González-Gay MÁ; Ferraz-Amaro I
J Rheumatol; 2019 May; 46(5):483-491. PubMed ID: 30647175
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry.
Fernández-Nebro A; Rúa-Figueroa Í; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; Ordóñez-Cañizares C; Martín-Martínez MA; Blanco R; Melero-González R; Ibáñez-Rúan J; Bernal-Vidal JA; Tomero-Muriel E; Uriarte-Isacelaya E; Horcada-Rubio L; Freire-González M; Narváez J; Boteanu AL; Santos-Soler G; Andreu JL; Pego-Reigosa JM
Medicine (Baltimore); 2015 Jul; 94(29):e1183. PubMed ID: 26200625
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and factors associated with hypertension in young and old women with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos JA; Navarrete-Navarrete N; Mediavilla JD; Jiménez-Jáimez J; Díaz-Chamorro A; Jiménez-Alonso J;
J Rheumatol; 2011 Jun; 38(6):1026-32. PubMed ID: 21406497
[TBL] [Abstract][Full Text] [Related]
7. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus.
Magder LS; Petri M
Am J Epidemiol; 2012 Oct; 176(8):708-19. PubMed ID: 23024137
[TBL] [Abstract][Full Text] [Related]
8. The characteristics and risk factors of cerebrovascular events in young systemic lupus erythematosus patients: A case-control study.
Hsu UH; Lin YT; Chiang BL
J Formos Med Assoc; 2024 Apr; 123(4):478-486. PubMed ID: 37813767
[TBL] [Abstract][Full Text] [Related]
9. Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus.
Bultink IE; Teerlink T; Heijst JA; Dijkmans BA; Voskuyl AE
Ann Rheum Dis; 2005 Sep; 64(9):1362-5. PubMed ID: 16100343
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index.
Palmieri V; Migliaresi P; Orefice M; Lupo T; Di Minno MN; Valentini G; Celentano A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):234-40. PubMed ID: 19157818
[TBL] [Abstract][Full Text] [Related]
11. Relationship between homocysteine levels and hypertension in systemic lupus erythematosus.
Sabio JM; Vargas-Hitos JA; Martinez-Bordonado J; Navarrete-Navarrete N; Díaz-Chamorro A; Olvera-Porcel C; Zamora-Pasadas M; Jiménez-Alonso J
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1528-35. PubMed ID: 24692389
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
Akawatcharangura P; Taechakraichana N; Osiri M
Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
[TBL] [Abstract][Full Text] [Related]
15. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
[TBL] [Abstract][Full Text] [Related]
16. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.
Murray SG; Yazdany J; Kaiser R; Criswell LA; Trupin L; Yelin EH; Katz PP; Julian LJ
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1328-33. PubMed ID: 22549897
[TBL] [Abstract][Full Text] [Related]
18. Dietary Inflammatory Index Score and Cardiovascular Disease Risk Markers in Women with Systemic Lupus Erythematosus.
Pocovi-Gerardino G; Correa-Rodríguez M; Callejas-Rubio JL; Ríos-Fernández R; Martín-Amada M; Cruz-Caparros MG; Rueda-Medina B; Ortego-Centeno N
J Acad Nutr Diet; 2020 Feb; 120(2):280-287. PubMed ID: 31492654
[TBL] [Abstract][Full Text] [Related]
19. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.
Ajeganova S; Hafström I; Frostegård J
Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33547230
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia.
Kanapathy A; Nik Jaafar NR; Shaharir SS; Chan LF; Rozita M; Ch'ng SS
Lupus; 2019 Jun; 28(7):854-861. PubMed ID: 31159651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
